Facephi Biometria SA (ES:FACE)
BME:FACE
Want to see ES:FACE full AI Analyst Report?
FACE Stock Chart & Stats
€2.53
€0.00(0.00%)
At close: 4:00 PM EST
€2.53
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.90 - €2.88
Previous CloseN/A
Volume1.96K
Average Volume (3M)21.10K
Market Cap
€59.78M
Enterprise Value€65.08M
Total Cash (Recent Filing)€2.21M
Total Debt (Recent Filing)€7.20M
Price to Earnings (P/E)162.3
Beta0.18
Next Earnings
Oct 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding26,624,086
10 Day Avg. Volume10,893
30 Day Avg. Volume21,097
Financial Highlights & Ratios
PEG Ratio-1.75
Price to Book (P/B)3.07
Price to Sales (P/S)1.86
P/FCF Ratio-47.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)€46.10M
Bulls Say, Bears Say
Bulls Say
Return To Profitability & Revenue GrowthA return to positive EBIT and net income alongside 20.7% revenue growth in 2025 indicates the core biometric licensing and services model can scale profitably. This durable improvement supports reinvestment, reduces refinancing pressure, and improves runway for strategic initiatives over the next several quarters.
Stronger Operating Cash GenerationMaterial improvement in operating cash flow (~€7.3M) shows the business is converting sales into cash more effectively. Sustainable OCF provides funding for R&D, customer deployments, and working capital, lowering dependence on external financing and supporting medium-term operational stability.
Improved Leverage And Balance Sheet FlexibilityA reduced debt-to-equity ratio (~0.33) and sizable equity base increase financial flexibility, lowering interest and refinancing risk. This stronger capital structure enables the company to absorb shocks, pursue partnerships or investments, and support longer sales cycles common in enterprise biometric deployments.
Bears Say
Negative Free Cash FlowPersistently negative free cash flow (~-€1.4M) means capital expenditures or working capital use still outpace operating cash inflows. Over months this limits the firm's ability to self-fund growth initiatives, may force external financing, and constrains shareholder return capacity if not reversed.
Thin Net MarginsA ~1% net margin leaves minimal buffer against cost variability or pricing pressure in competitive identity markets. Thin margins restrict reinvestment and make earnings sensitive to small revenue or cost swings, raising execution risk for sustained profitable scaling over the medium term.
Historical Earnings Volatility And Low ROEPrior large losses (2023-2024) and a low ROE (~1.7%) signal inconsistent profitability and weak capital efficiency. Such volatility undermines investor confidence and indicates management must consistently execute to deliver compoundable returns; persistent inconsistency raises long-term execution risk.
Facephi Biometria SA News
FACE FAQ
What was Facephi Biometria SA’s price range in the past 12 months?
Facephi Biometria SA lowest stock price was €1.90 and its highest was €2.88 in the past 12 months.
What is Facephi Biometria SA’s market cap?
Facephi Biometria SA’s market cap is €59.78M.
When is Facephi Biometria SA’s upcoming earnings report date?
Facephi Biometria SA’s upcoming earnings report date is Oct 22, 2026 which is in 143 days.
How were Facephi Biometria SA’s earnings last quarter?
Currently, no data Available
Is Facephi Biometria SA overvalued?
According to Wall Street analysts Facephi Biometria SA’s price is currently Overvalued.
Does Facephi Biometria SA pay dividends?
Facephi Biometria SA does not currently pay dividends.
What is Facephi Biometria SA’s EPS estimate?
Facephi Biometria SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Facephi Biometria SA have?
Facephi Biometria SA has 26,624,086 shares outstanding.
What happened to Facephi Biometria SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Facephi Biometria SA?
Currently, no hedge funds are holding shares in ES:FACE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Facephi Biometria SA
Facephi Biometria, S.A. provides biometric facial recognition technology solutions primarily for banking sector in Latin America, the United States, Asia, and internationally. Its products include Facephi Beyond Biometrics, a multi-biometric solution for digital identity verification that allows the client to design various digital onboarding and authentication processes; SelphID, a digital onboarding solution that allows user registry or the contracting of a product from any location; and Selphi, an authentication solution that allows user identity verification through biometric technology. The company's solutions also include Look&Phi, PhiVox, inPhinite, and SignPhi. Its solutions are used in financial services, insurance, healthcare, telecommunication, travelling and transportation, public administration, shared mobility industries, as well as sports events. The company was incorporated in 2012 and is headquartered in Alicante, Spain.
Technical Analysis
Izertis SA
―
Substrate Artificial Intelligence SA
―
Airtificial Intelligence Structures SA
―
Seresco SA
―
Aplicaciones y Tratamiento de Sistemas, S.A.
―